MX2013006353A - Metodos y composiciones utiles para promover el sueño en animales. - Google Patents
Metodos y composiciones utiles para promover el sueño en animales.Info
- Publication number
- MX2013006353A MX2013006353A MX2013006353A MX2013006353A MX2013006353A MX 2013006353 A MX2013006353 A MX 2013006353A MX 2013006353 A MX2013006353 A MX 2013006353A MX 2013006353 A MX2013006353 A MX 2013006353A MX 2013006353 A MX2013006353 A MX 2013006353A
- Authority
- MX
- Mexico
- Prior art keywords
- animal
- methods
- animals
- compositions useful
- sleep
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 7
- 230000001737 promoting effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000037396 body weight Effects 0.000 abstract 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 2
- 229940022405 astaxanthin Drugs 0.000 abstract 2
- 235000013793 astaxanthin Nutrition 0.000 abstract 2
- 239000001168 astaxanthin Substances 0.000 abstract 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 2
- 229960003987 melatonin Drugs 0.000 abstract 2
- 239000011701 zinc Substances 0.000 abstract 2
- 229910052725 zinc Inorganic materials 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Abstract
Se proporcionan métodos y composiciones para promover el sueño en un animal. En un aspecto general, una cantidad promotora del sueño de astaxantina y una cantidad promotora del sueño de melatonina se administran juntas a un animal. La astaxantina se puede administrar en una cantidad que varíe de aproximadamente 0.1 a aproximadamente 60 mg/kg/peso corporal del animal. La melatonina se puede administrar en una cantidad que varíe de aproximadamente 0.1 a aproximadamente 40 mg/kg/peso corporal del animal. El método puede comprender además administrar conjuntamente una cantidad promotora del sueño de zinc al animal. El zinc puede ser administrado en una cantidad que varíe de aproximadamente 10 a aproximadamente 100 mg/kg/de peso corporal del animal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45918110P | 2010-12-07 | 2010-12-07 | |
| PCT/US2011/060597 WO2012078317A1 (en) | 2010-12-07 | 2011-11-14 | Methods and compositions useful for promoting sleep in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013006353A true MX2013006353A (es) | 2013-08-26 |
Family
ID=46207452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013006353A MX2013006353A (es) | 2010-12-07 | 2011-11-14 | Metodos y composiciones utiles para promover el sueño en animales. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130273176A1 (es) |
| EP (1) | EP2648513A4 (es) |
| JP (1) | JP2014505031A (es) |
| CN (1) | CN103228139A (es) |
| AU (1) | AU2011338846B2 (es) |
| BR (1) | BR112013016554A2 (es) |
| CA (1) | CA2819595A1 (es) |
| MX (1) | MX2013006353A (es) |
| RU (1) | RU2594876C2 (es) |
| WO (1) | WO2012078317A1 (es) |
| ZA (1) | ZA201305086B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2014054651A1 (ja) * | 2012-10-03 | 2016-08-25 | 富士フイルム株式会社 | 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 |
| JPWO2015099102A1 (ja) * | 2013-12-27 | 2017-03-23 | 富士フイルム株式会社 | 亜鉛含有睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 |
| CN110882245A (zh) * | 2019-12-16 | 2020-03-17 | 厦门市健康医疗大数据中心(厦门市医药研究所) | 一种改善睡眠的组合物及其用途 |
| ES2837877A1 (es) * | 2019-12-31 | 2021-07-01 | Laboratorios Vinas S A | Composicion galenica, para uso oral, liquida, que comprende melatonina y una sal de zinc y metodo y uso correspondientes |
| KR102682447B1 (ko) * | 2021-06-29 | 2024-07-04 | 주식회사 엘지생활건강 | 히노키티올을 함유하는 구강용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0951842B1 (en) * | 1999-01-20 | 2002-12-04 | N.V. Nutricia | Infant formula |
| US7211280B1 (en) * | 1999-09-09 | 2007-05-01 | Nestec S.A. | Condition of elderly pets |
| ATE406882T1 (de) * | 2000-05-16 | 2008-09-15 | Suntory Ltd | Zusammensetzungen zur normalisierung des zirkadianen rythmus |
| US20020120001A1 (en) * | 2000-10-13 | 2002-08-29 | Ashni Naturaceuticals, Inc. | Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect |
| US6974841B1 (en) * | 2002-09-27 | 2005-12-13 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement |
| US20050249785A1 (en) * | 2003-08-13 | 2005-11-10 | Gordon John G | Use of melatonin-containing oral supplement with animals |
| WO2005058064A1 (ja) * | 2003-12-19 | 2005-06-30 | Menicon Co., Ltd. | アスタキサンチン配合ペット用食物 |
| WO2005097101A1 (ja) * | 2004-04-06 | 2005-10-20 | Taiyokagaku Co., Ltd. | 睡眠改善用組成物 |
| EP2007368A2 (en) * | 2006-04-04 | 2008-12-31 | Hill's Pet Nutrition Inc. | Compositions and methods for enhancing the antioxidant status of animals |
| ES2593880T3 (es) * | 2009-09-11 | 2016-12-13 | Nestec, S.A. | Composiciones y métodos para mejorar las funciones cognitivas y relacionadas en animales |
-
2011
- 2011-11-14 BR BR112013016554A patent/BR112013016554A2/pt not_active IP Right Cessation
- 2011-11-14 EP EP11847183.8A patent/EP2648513A4/en not_active Withdrawn
- 2011-11-14 JP JP2013543177A patent/JP2014505031A/ja active Pending
- 2011-11-14 MX MX2013006353A patent/MX2013006353A/es unknown
- 2011-11-14 US US13/991,716 patent/US20130273176A1/en not_active Abandoned
- 2011-11-14 AU AU2011338846A patent/AU2011338846B2/en not_active Ceased
- 2011-11-14 CA CA2819595A patent/CA2819595A1/en not_active Abandoned
- 2011-11-14 WO PCT/US2011/060597 patent/WO2012078317A1/en not_active Ceased
- 2011-11-14 CN CN201180057829XA patent/CN103228139A/zh active Pending
- 2011-11-14 RU RU2013131098/13A patent/RU2594876C2/ru not_active IP Right Cessation
-
2013
- 2013-07-05 ZA ZA2013/05086A patent/ZA201305086B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011338846B2 (en) | 2016-04-14 |
| RU2013131098A (ru) | 2015-01-20 |
| ZA201305086B (en) | 2014-12-23 |
| BR112013016554A2 (pt) | 2016-07-12 |
| AU2011338846A1 (en) | 2013-06-13 |
| WO2012078317A1 (en) | 2012-06-14 |
| CN103228139A (zh) | 2013-07-31 |
| CA2819595A1 (en) | 2012-06-14 |
| EP2648513A1 (en) | 2013-10-16 |
| JP2014505031A (ja) | 2014-02-27 |
| RU2594876C2 (ru) | 2016-08-20 |
| US20130273176A1 (en) | 2013-10-17 |
| EP2648513A4 (en) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| NZ595987A (en) | A novel formulation of diclofenac | |
| NZ722319A (en) | A novel formulation of meloxicam | |
| PH12013500923A1 (en) | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative | |
| NZ706990A (en) | A veterinary method of alleviating noise aversion | |
| MX2013006353A (es) | Metodos y composiciones utiles para promover el sueño en animales. | |
| AU2016216741A1 (en) | Compositions and methods of use of an inappetance-controlling compound | |
| NZ595798A (en) | Ectoparasiticidal methods and formulations | |
| NZ587941A (en) | Methods to inhibit tumor cell growth by using lansoprazole | |
| MX2013013098A (es) | Metodos y composiciones para fomentar el crecimiento de la masa corporal magra. | |
| MY160509A (en) | Adiponectin production accelerating composition | |
| MX2013014430A (es) | Metodos para reducir neurodegeneracion. | |
| WO2012134590A3 (en) | Calcium supplement | |
| WO2013052433A3 (en) | Methods and compositions for reducing food intake and body weight gain in animals | |
| MX2013012990A (es) | Metodos y composiciones para preservar la masa corporal magra durante la perdida de peso. | |
| RU2011134662A (ru) | Способ предотвращения развития стрессовых реакций в организме животных | |
| RU2009121969A (ru) | Способ предотвращения развития стрессовых реакций в организме животных | |
| TH143143A (th) | วิธีและองค์ประกอบที่มีประโยชน์สำหรับชักนำให้สัตว์นอนหลับ | |
| UA67215U (ru) | Способ создания модели отравления крыс наночастицами свинца | |
| UA42066U (ru) | Способ лечения телят при эймериозно-стронгилоидозной инвазии | |
| UA56367U (en) | composition neuroactive preparation | |
| WO2007064547A3 (en) | Morinda citrifolia based formulation and methods for weight management | |
| UA55533U (ru) | Ажених тваринспособ профилактики нарушений морфофункциональных свойств тканей печени в онтогенезе потомков гамма-облученных и подвергнутых стрессу животных | |
| RU2010146367A (ru) | Способ моделирования экспериментального амилоидоза у животных | |
| UA67214U (ru) | Способ выведения свинца из организма животных |